标题/作者	年份
The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review J Vanhamel, A Rotsaert, T Reyniers, C Nöstlinger, M Laga, ... BMC Health Services Research 20, 1-18	2020
Preferences for current and future PrEP modalities among PrEP-experienced gay and bisexual men in Australia C Chan, S Vaccher, D Fraser, AE Grulich, M Holt, I Zablotska-Manos, ... AIDS and Behavior 26 (1), 88-95	2022
Challenges of providing HIV pre-exposure prophylaxis across Australian clinics: qualitative insights of clinicians AKJ Smith, B Haire, CE Newman, M Holt Sexual Health 18 (2), 187-194	2021
Health care providers’ attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe M Lanham, K Ridgeway, M Mireku, D Nhamo, D Pillay, M Murire, ... BMC Health Services Research 21 (1), 1-12	2021
Why are patients switching from tenofovir disoproxil fumarate/emtricitabine (Truvada) to tenofovir alafenamide/emtricitabine (Descovy) for pre-exposure prophylaxis? AB D'Angelo, DA Westmoreland, PB Carneiro, J Johnson, C Grov AIDS patient care and STDs 35 (8), 327-334	2021
Barriers and facilitators to HIV pre-exposure prophylaxis uptake, adherence, and persistence among transgender populations in the United States: a systematic review M Dang, AI Scheim, M Teti, KG Quinn, M Zarwell, AE Petroll, KJ Horvath, ... AIDS Patient Care and STDs 36 (6), 236-248	2022
Determinants of implementation for HIV pre-exposure prophylaxis based on an updated consolidated framework for implementation research: a systematic review DH Li, N Benbow, B Keiser, M Mongrella, K Ortiz, J Villamar, C Gallo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 90 (1), S235-S246	2022
Correlates of PrEP uptake among young sexual minority men and transgender women in New York City: the need to reframe “Risk” messaging and normalize preventative health J Jaiswal, C LoSchiavo, S Meanley, K Hascher, AB Cox, KB Dunlap, ... AIDS and Behavior 25, 3057-3073	2021
Awareness of HIV preexposure prophylaxis among people at risk for HIV: results from the 2017–2019 National Survey of Family Growth S Keddem, ME Dichter, AB Hamilton, S Chhatre, S Sonalkar Sexually Transmitted Diseases 48 (12), 967-972	2021
Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: examining concordance between pharmacy technicians and pharmacists R Hopkins, D Josma, J Morris, DG Klepser, HN Young, ND Crawford Journal of the American Pharmacists Association 61 (1), 115-120	2021
Patient-led decision-making for HIV preexposure prophylaxis WC Sewell, P Solleveld, D Seidman, C Dehlendorf, JL Marcus, ... Current HIV/AIDS Reports 18, 48-56	2021
A typology of power in implementation: building on the exploration, preparation, implementation, sustainment (EPIS) framework to advance mental health and HIV health equity MC Stanton, SB Ali, the SUSTAIN Center Team Implementation Research and Practice 3, 26334895211064250	2022
An experimental study of the effects of patient race, sexual orientation, and injection drug use on providers’ PrEP-related clinical judgments SK Calabrese, DA Kalwicz, D Modrakovic, VA Earnshaw, EJ Edelman, ... AIDS and Behavior, 1-29	2022
Knowledge of HIV and HIV pre-exposure prophylaxis among medical and pharmacy students: A national, multi-site, cross-sectional study SR Bunting, BA Feinstein, A Hazra, NK Sheth, SS Garber Preventive medicine reports 24, 101590	2021
Health service-and provider-level factors influencing engagement in HIV pre-exposure prophylaxis care among male sex workers PK Valente, MJ Mimiaga, PA Chan, KB Biello AIDS Patient Care and STDs 35 (8), 279-287	2021
Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system AMA Agovi, I Anikpo, MJ Cvitanovich, KJ Craten, EO Asuelime, RP Ojha Preventive medicine reports 20, 101266	2020
Regional disparities in qualified health plans’ prior authorization requirements for HIV pre-exposure prophylaxis in the United States KA McManus, S Powers, A Killelea, S Tello-Trillo, ER McQuade JAMA Network Open 3 (6), e207445-e207445	2020
Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data R Schaefer, PHA da Costa Leite, R Silva, QA Karim, C Akolo, CF Cáceres, ... The Lancet HIV	2022
Primary care Providers’ knowledge, attitudes, and beliefs about HIV Pre-exposure prophylaxis (PrEP): Informing network-based interventions ED Storholm, AJ Ober, ML Mizel, L Matthews, M Sargent, I Todd, ... AIDS Education and Prevention 33 (4), 325-344	2021
Next generation pre-exposure prophylaxis for young men who have sex with men: Lessons from system and provider-level barriers to oral PrEP PK Valente, JA Bauermeister, WY Lin, D Operario, J Rusley, ... AIDS and Behavior 26 (10), 3422-3435	2022

1 - 20

计算机程序会自动估算并确定日期和引用次数。